The journal found that the studies, which had suggested that medication abortion is unsafe, included incorrect factual assumptions and misleading presentation of the data.
Read More Abortion, Decisions and Verdicts, Abortion Drugs, Mifeprex (RU-486), Suits and Litigation (Civil), Conflicts of Interest, Research, Federal Courts (US), Courts and the Judiciary, Medicine and Health, Drugs (Pharmaceuticals), Sage Publications, Supreme Court (US), Food and Drug Administration, Kacsmaryk, Matthew
